NCT04526353

Early Oxybutinin Treatment for Boys With Posterior Urethral Valves

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2020-09-10Est. Completion: 2028-02

Enrollment target: 50 participants

Locations

CHU de Bordeaux, Bordeaux, France

Contact

Luke L HARPER, MDluke.harper@chu-bordeaux.fr 05 56 79 56 17

Aurore A CAPELLI, PhDaurore.capelli@chu-bordeaux.fr 05 57 82 08 77

Other microbiome trials you might be interested in

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell CancerPhase 2Recruiting

Localized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8Stage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8

This phase II trial studies how well ivonescimab works prior to surgery in treating patients with high-risk clear cell k…

Duarte, United StatesEst. completion Sep 8, 2027

View Trial →

A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate CancerPhase 1Recruiting

Prostate Cancer

The purpose of this study is to evaluate the efficacy, and safety of HRS-5041 tablets combined with antitumor therapy in…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.